Definition

This is an exome analysis performed in pregnancies with a detected fetal structural anomaly where chromosomal microarray/karyotype results are non-diagnostic; in systematic reviews, additional diagnostic yield in CMA/karyotype-negative cases was found to be 31%. Diagnostic yield varies greatly by phenotype, reaching up to 53% in isolated skeletal anomalies.

Method

Next-Generation Sequencing

Accepted sample types

EDTA Blood, Amniocentesis, Cordocentesis, CVS

Description

Analyzes exons and exon-intron junction regions belonging to ~22,000 gene regions. A maternal contamination test is included. Investigates gene-level changes of unknown cause. Analysis depth is 100X coverage.

Inheritance

Studied in a germline context, hereditary/de novo variants are searched for in fetal DNA.

Related Tests

Inheritance Patterns

Describes how a genetic condition is passed on within a family. There are five main patterns

Go to term →

Carrier (Heterozygous / Homozygous)

Why it matters: In autosomal recessive inheritance, when each parent is a carrier (while both appear healthy), the chance of their child being born with the disease is 25% in each

Go to term →

VUS (Variant of Uncertain Significance)

This is the situation where the test has detected a change in the DNA, but the role of this change in the development of disease is unconfirmed.

Go to term →

How to Read a Genetic Test Result (Positive / Negative / VUS)

A genetic test result falls into three main categories

Go to term →

Types of Genetic Tests

A genetic test is a type of medical test that detects changes in genes, chromosomes or proteins. Today there are more than 77,000 genetic tests available.

Go to term →